Sponsor:
Signos Inc
Code:
NCT05874635
Conditions
Weight Loss
Metabolic Syndrome
Diabetes Mellitus, Type 2
Central Obesity
Insulin Resistance
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
Continuous Glucose Monitor Device
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-15. This information was provided to ClinicalTrials.gov by Signos Inc on 2024-01-12.